About Maxwell Biosciences
Maxwell Biosciences is a private company based in Austin, Texas. It has reported $10,850,247 raised in two offerings on Form D since April 2022. Its chief executive is Joshua McClure.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Not yet | Jul 14, 2023 | $0of $25.0M target | 0 | — | DebtRule 506(b) | Form D ↗ |
| Oct 4, 2021 | Apr 5, 2022 | $10,850,247of $14.8M target | 96 | $113K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $10,850,247 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Maxwell Biosciences's Form D filed Jul 14, 2023.
JM
Joshua McClure
President and CEO, director
KM
Kate McKinley
Director
PT
Praveen Tyle
Director
BH
Barbara Holcomb
Director
AB
Annelise Barron
Director
Earlier filings also listed Theodore Moskovitz (director, last listed Apr 2022) and Christopher Johns (director, last listed Apr 2022).